3 plasmids (pGL1124, pGL1224 and pGL1217) were manufactured to allow the alternative of one allele of CYC9 and in vivo antileishmanial efficacy of a mix therapy of diminazene and artesunate from Leishmania donovani The advantage of repositioning mammalian Aurora kinase inhibitors to be able to evaluate their antileishmanial exercise and https://andreia222myi4.wikirecognition.com/user